MedTrace Logo

Neopterin Effects on Ischemic Stroke

NCT02974192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-01-18

No results posted yet for this study

Summary

Ischemic stroke accounts for the majority of stroke cases and constitutes a major cause of death and disability in industrial world. Inflammation has been reported to constitute a major component of ischemic stroke pathology. The brain responds to ischemic injury with an acute andprolonged inflammatory process. Few studies have investigated the relationship between acute biomarkers of inflammation and functional outcome following stroke

Conditions

Interventions

OTHER

Neopterin

Neopterin will be measured by using standard laboratory methods on the first day of admission.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Sayed k Abd-Elshafy, MD · Associate professor of anesthesia

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974192 on ClinicalTrials.gov